AI assistant
Sending…
INFRATIL LIMITED. — Director's Dealing 2017
Mar 9, 2017
65106_rns_2017-03-09_10ec19f5-1957-4641-a82b-36c32439d3ae.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [78 x 21] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | |||
|---|---|---|---|
| Name of listed issuer: | Infratil limited | ||
| Date this disclosure made: | 9-Mar-17 | ||
| Date of last disclosure: | 22-Mar-16 | ||
| Director or senior managergiving disclosure | |||
| Full name(s): | Lib Petagna | ||
| Name of listed issuer: | |||
| Name of related body corporate (if applicable): | Morrison & Co | ||
| Position held in listed issuer: | Trainee Tech & Form Analyst | ||
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | |||
| Class of affected quoted financial products: | Ordinary shares | ||
| Nature of the affected relevant interest(s): | Beneficial | ||
| For that relevant interest- | |||
| Number held in class before acquisition or disposal: | 2,169,242 | ||
| Number held in class after acquisition or disposal: | 1,169,242 | ||
| Current registered holder(s): | JML capital limited | ||
| Registered holder(s) once transfers are registered: | |||
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | |||
| Type of affected derivative: | |||
| Class of underlyingfinancialproducts: | |||
| Details of affected derivative- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial | |||
| products(if any): | |||
| A statement as to whether the derivative is cash settled orphysicallysettled: | |||
| Maturitydate of the derivative (if any): | |||
| Expirydate of the derivative(if any): | |||
| Theprice specified in the terms of the derivative(if any): | |||
| Any other details needed to understand how the amount of the consideration payable under | |||
| the derivative or the value of the derivative is affected by the value of the underlying financial | |||
| products: | |||
| _For that derivative,- _ | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | |||
| interest in the derivative: | |||
| Details of transactions giving rise to acquisition or disposal | |||
| Total number of transactions to which notice relates: | 1 | ||
| Details of transactions requiring disclosure- | |||
| Date of transaction: | 3-Mar-16 | ||
| Nature oftransaction: | Sale | ||
| Name of any other party or parties to the transaction (if known): | On market | ||
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or | |||
| disposal. If the consideration was not in cash and cannot be readily by converted into a cash | |||
| value, describe the consideration: | 2.91 per share | ||
| Number of financial products to which the transaction related: | 1,000,000 | ||
| If the issuer has a financial products trading policy that prohibits directors or senior | |||
| managers from trading during any period without written clearance (a closed period) include | |||
| the following details— | |||
| Whether relevant interests were acquired or disposed of during a closed period: | |||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed | |||
| duringthe closedperiod: | Yes | ||
| Date of the prior written clearance (if any): | 1-Mar | ||
| Certification | |||
| I certify that, to the best of my knowledge and belief, the information contained in this | |||
| disclosure is correct and that I am duly authorised to make this disclosure by all persons for | |||
| whom it is made. | |||
| Signature of director or officer: | |||
| Date of signature: | 8-Mar | ||
| or | |||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorisedperson: |
�1
More from INFRATIL LIMITED.
Regulatory Filings
2026
Jun 4
Regulatory Filings
2026
Jun 3
Director's Dealing
2026
Jun 2
Director's Dealing
2026
Jun 2
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Interest Rate Update/Notice
2026
May 27
Interest Rate Update/Notice
2026
May 27
Interest Rate Update/Notice
2026
May 26
Capital/Financing Update
2026
May 26